Neurology Minute
1,957 episodes — Page 39 of 40
Approach to Diagnosing Genetic Ataxias
Dr. Stephan Pulst discusses approaches to diagnosing genetic ataxias.
Rising Out-of-Pocket Costs for Common Neurologic Medications
Dr. Brian Callaghan talks about the rise in out-of-pocket costs for commonly prescribed neurologic medications.
Continuum Pearls: Optimizing Management of Medically Responsive Epilepsy, Part 3
Dr. Derek Bauer discusses how to optimize epilepsy management. To learn more, read the article "Optimizing Management of Medically Responsive Epilepsy" by Dr. Bauer in the April 2019 Epilepsy issue of Continuum.
Continuum Pearls: Optimizing Management of Medically Responsive Epilepsy, Part 2
Dr. Derek Bauer offers tips for epilepsy neurologists with more experience in optimizing epilepsy management. To learn more, read the article "Optimizing Management of Medically Responsive Epilepsy" by Dr. Bauer in the April 2019 Epilepsy issue of Continuum.
Continuum Pearls: Optimizing Management of Medically Responsive Epilepsy
Dr. Derek Bauer discusses optimizing management of medically responsive epilepsy. To learn more, read the article "Optimizing Management of Medically Responsive Epilepsy" by Dr. Bauer in the April 2019 Epilepsy issue of Continuum.
Continuum Pearls: Important Takeaways in Evaluating Seizure Etiology
Dr. Stephan U. Schuele offers important takeaways in evaluating seizure etiology. To learn more, read the article "Evaluation of Seizure Etiology from Routine Testing to Genetic Evaluation" by Dr. Schuele in the April 2019 Epilepsy issue of Continuum.
Long-term Outcomes of NeuroZika
Dr. Stacey Clardy discusses discusses takeaways from Dr. Annie Lannuzel's paper on the long-term outcomes of NeuroZika.
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors (NEJM)
Dr. Stuart Connolly discusses the main takeaways from his NEJM paper on andexanet alfa for Bleeding Associated with Factor Xa Inhibitors. Read the paper in the New England Journal of Medicine: https://www.nejm.org/doi/full/10.1056/NEJMoa1814051.
Talking to Legislators on PCORI
Dr. Jason Crowell discusses the importance of talking to legislators about PCORI. Share your story on the AAN Advocacy Action Center at https://www.aan.com/policy-and-guidelines/advocacy/aan-advocacy-action-center/.
Continuum Pearls: Evaluating Seizure Etiology, pt. 2
Dr. Stephan U. Schuele discusses the evaluation of seizure etiology for neurologists with more experience. To learn more, read the article "Evaluation of Seizure Etiology from Routine Testing to Genetic Evaluation" by Dr. Schuele in the April 2019 Epilepsy issue of Continuum.
Continuum Pearls: Evaluation of Seizure Etiology From Routine Testing to Genetic Evaluation
Dr. Stephan U. Schuele discusses the evaluation of seizure etiology. To learn more, read the article "Evaluation of Seizure Etiology from Routine Testing to Genetic Evaluation" by Dr. Schuele in the April 2019 Epilepsy issue of Continuum.
Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus
Dr. Ivan Sanchez Fernandez discusses the main points from his paper on meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus.
Measles in 2019 with Dr. Anthony Fauci
Dr. Anthony Fauci discusses the main points on his paper on measles in 2019. "Measles in 2019--Going Backward" can be found in the New England Journal of Medicine here: https://www.nejm.org/doi/full/10.1056/NEJMp1905099.
STEP Therapy & Results of AAN Advocacy Efforts for Patients with Neurological Disease
Dr. Jason Crowell discusses STEP therapy and recent advocacy efforts by the AAN at Neurology on the Hill. Read the AAN Capitol Hill Report from April 22nd for more: https://www.aan.com/policy-and-guidelines/advocacy/capitol-hill-report/.
Continuum Pearls: Posterior Cortical Atrophy
Dr. Jonathan Graff-Radford, guest editor of the February 2019 Continuum Dementia issue, discusses posterior cortical atrophy. To learn more, read the article "Posterior Cortical Atrophy" by Dr. Jonathan M. Schott and Dr. Sebastian J. Crutch in that issue.
Treatment of Tics and People with Tourette's Syndrome
Dr. Tamara Pringsheim discusses guideline recommendations on assessment and management of tics in people with Tourette's Syndrome and chronic tic disorders.
Regulation on Human Gene Editing
New York Times staff writer Pam Belluck discusses the WHO and regulation on human gene editing. Read her March 19, 2019, article here: https://www.nytimes.com/2019/03/19/health/who-panel-demands-a-registry-for-human-gene-editing.html.
Drug Prices for Lambert Eaton Myasthenic Syndrome
Dr. Jason Crowell discusses skyrocketing costs of a drug used for treatment with Lambert-Eaton myasthenic syndrome.
Medical Clerkships in Neurology
Dr. Rae Bacharach discusses trends in medical clerkships in neurology.
Continuum Pearls: Early-onset Alzheimer Disease
Dr. Jonathan Graff-Radford, guest editor of the February 2019 Continuum Dementia issue, discusses early-onset Alzheimer Disease. To learn more, read the article "Early-onset Alzheimer Disease and Its Variants" by Dr. Mario F. Mendez in that issue.
Dr. Jenny Linnoila discusses: Mouse model of anti-NMDA receptor post–herpes simplex encephalitis
Dr. Jenny Linnoila discusses the main takeaways from her podcast interview and paper on a mouse model of anti-NMDA receptor post-herpes simplex encephalitis.
Gene Editing and CRISPR
Pam Belluck of the New York Times discusses He Jiankui, gene editing and CRISPR. Read one of the articles on the issue here: https://www.nytimes.com/2019/04/14/health/gene-editing-babies.html
New FDA-Approved Treatments for MS
Dr. Rae Bacharach discusses two new, disease-modifying therapies for use in multiple sclerosis.
Continuum Pearls: Transient Epileptic Amnesia
Dr. Gregory Day discusses the recognition of transient epileptic amnesia. To learn more, read Dr. Day's article, "Reversible Dementias," in the February 2019 Dementia issue of Continuum.
Montreal Cognitive Assessment as a screening tool: Influence of performance and symptom validity
Dr. Brigid Waldron-Perrine talks about the Montreal Cognitive Assessment as a screening tool.
Use of Neurofilament Light as a Potential Biomarker for Alzheimer's Disease
Dr. Mathias Jucker discusses the use of neurofilament light as a potential biomarker for Alzheimer's Disease.
Continuum Pearls: Behavioral Variant Frontotemporal Dementia
Dr. Jonathan Graff-Radford, guest editor of the February 2019 Dementia issue of Continuum, discusses behavioral-variant frontotemporal dementia. To learn more, read the article "Behavioral Variant Frontotemporal Dementia" by Dr. William W. Seeley in that issue.
The comparative effectiveness of teriflunomide and dimethyl fumarate
Dr. Mathias Buron discusses the takeaways from his paper the comparative effectiveness of teriflunomide and dimethyl fumarate.
Joanna Hellmuth: The Rise of Pseudomedicine for Dementia and Brain Health
Dr. Joanna Hellmuth discusses the findings of her paper on the rise of pseudomedicine for dementia and brain health.
65-year-old female with subacute hemiballism
Dr. Roy Strowd discusses a recent Clinical Reasoning case about a 65-year-old female with subacute hemiballism.
Continuum Pearls: Hippocampal Sclerosis of Aging
Dr. Jonathan Graff-Radford, guest editor of the February 2019 Dementia issue of Continuum, discusses hippocampal sclerosis of aging. To learn more, read the article "Hippocampal Sclerosis, Argyrophilic Grain Disease, and Primary Age-related Tauopathy" by Drs. Gregory A. Jicha and Peter T. Nelson in that issue.
How much periventricular lesions assist in distinguishing migraine with aura from CIS?
Dr. Caterina Lapucci talks about her paper addressing how much periventricular lesions assist in distinguishing migraine with aura from CIS.
Drug Pricing and Drug Pricing Legislation
Sarah Karlin-Smith and Sarah Owermohle from Politico talk about drug pricing and legislation to affect drug pricing.
Pregnant Woman Presents with Chin Numbness
Dr. Roy Strowd showcases a Clinical Reasoning case on a pregnant woman presenting with chin numbness.
Continuum Pearls: Practical Approach to Recognizing Patients with Reversible Dementia
Dr. Gregory Day offers a practical approach to recognizing patients with reversible dementia. To learn more, read Dr. Day's article, "Reversible Dementias," in the February 2019 Dementia issue of Continuum.
Automated seizure detection accuracy for ambulatory EEG recordings
Dr. Stephan Schuele discusses the main takeaways from his paper on automated seizure detection accuracy for ambulatory EEG recordings.
SHINE Stroke Trial
Dr. Kevin Barrett discusses the SHINE stroke trial, which was designed to determine the optimal treatment of hyperglycemia in acute stroke.
Preview of 2019 AAN Annual Meeting
Dr. Joe Sirven previews the upcoming 2019 AAN Annual Meeting in Philadelphia.
Bilateral Wrist Pain in the Setting of Weight Loss
Dr. John Millichap discusses a clinical pediatric R&F case of a 15-year-old boy with bilateral wrist pain in the setting of weight loss.
Continuum Pearls: DESH as Imaging Finding When Evaluating Ventriculomegaly
Dr. Jonathan Graff-Radford, guest editor of the February 2019 Dementia issue of Continuum, discusses an important imaging finding when evaluating patients for ventriculomegaly called disproportionately large subarachnoid space hydrocephalus (DESH). To learn more, read the article "Normal Pressure Hydrocephalus" by Drs. Neill R. Graff-Radford and David T. Jones in that issue.
The future of hospital systems & healthcare
Dr. Stephen Klasko talks about the future of hospital systems and healthcare, based on a panel at the World Economic Forum in Davos.
Effect of prolonged antibiotic treatment on cognitive performance in patients with Lyme borreliosis
Dr. Anneleen Berende discusses the effect of prolonged antibiotic treatment on cognitive performance in patients with Lyme borreliosis.
Benefit of Prolonged Antibiotics in on Cognitive Performance in Lyme borreliosis
Dr. Anneleen Berende discusses whether or not prolonged antibiotics are beneficial for neurocognition in Lyme borreliosis.
S1 Ep 10The Future of Hospital Systems & Healthcare
Dr. Stephen Klasko talks about the future of hospital systems and healthcare, based on a panel at the World Economic Forum.
AAN Annual Meeting Preview
Dr. Joe Sirven previews the 2019 AAN Annual Meeting.
West syndrome, Pontocerebellar hypoplasia and Hypomyelination
Dr. John Millichap discusses a recent pediatric R&F case on West syndrome, pontocerebellar hypoplasia, and Hypomyelination in a 6-month-old boy.
Continuum Pearls: Criteria for Dementia with Lewy Bodies
Dr. Jonathan Graff-Radford, guest editor of the February 2019 Dementia issue of Continuum, discusses updates to criteria for dementia with Lewy bodies. To learn more, read the article "Lewy Body Dementias" by Dr. Melissa J. Armstrong in that issue.
Levodopa in Parkinson's Disease
Dr. Jason Crowell talks with Dr. Rob de Bie about when to start Levodopa in Parkinson's Disease.
What's Trending: Delayed Start of Levodopa in Parkinson's
Dr. Jason Crowell discusses delayed start of levodopa for Parkinson's with Dr. Rob de Bie. Dr. de Bie's article can be found here: https://www.nejm.org/doi/full/10.1056/NEJMoa1809983.
The 2019 AAN Annual Meeting
Dr. Stacey Clardy reminds you to join us at the 2019 American Academy of Neurology Annual Meeting.